CEL-SCI Corp. (CVM)
1.59
-0.02
(-1.24%)
USD |
NYAM |
Aug 27, 14:10
CEL-SCI 1 Year Total Returns (Daily) : -85.75% for Aug. 26, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 26, 2026 | -85.75% |
| August 25, 2026 | -85.98% |
| August 24, 2026 | -85.50% |
| August 21, 2026 | -84.51% |
| August 20, 2026 | -83.60% |
| August 19, 2026 | -80.64% |
| August 18, 2026 | -82.17% |
| August 17, 2026 | -82.18% |
| August 14, 2026 | -81.08% |
| August 13, 2026 | -82.16% |
| August 12, 2026 | -80.60% |
| August 11, 2026 | -78.38% |
| August 10, 2026 | -79.97% |
| August 07, 2026 | -79.10% |
| August 06, 2026 | -82.39% |
| August 05, 2026 | -83.00% |
| August 04, 2026 | -85.30% |
| August 03, 2026 | -86.77% |
| July 31, 2026 | -85.82% |
| July 30, 2026 | -85.78% |
| July 29, 2026 | -84.06% |
| July 28, 2026 | -86.06% |
| July 27, 2026 | -85.61% |
| July 24, 2026 | -82.77% |
| July 23, 2026 | -81.08% |
| Date | Value |
|---|---|
| July 22, 2026 | -76.66% |
| July 21, 2026 | -71.26% |
| July 20, 2026 | -67.93% |
| July 17, 2026 | -71.94% |
| July 16, 2026 | -70.13% |
| July 15, 2026 | -67.42% |
| July 14, 2026 | -68.32% |
| July 13, 2026 | -65.44% |
| July 10, 2026 | -63.87% |
| July 09, 2026 | -51.79% |
| July 08, 2026 | -42.21% |
| July 07, 2026 | -44.10% |
| July 06, 2026 | -49.00% |
| July 02, 2026 | -54.76% |
| July 01, 2026 | -55.70% |
| June 30, 2026 | -54.59% |
| June 29, 2026 | -55.00% |
| June 26, 2026 | -54.51% |
| June 25, 2026 | -59.57% |
| June 24, 2026 | -59.05% |
| June 23, 2026 | -58.54% |
| June 22, 2026 | -60.39% |
| June 18, 2026 | -54.59% |
| June 17, 2026 | -52.59% |
| June 16, 2026 | -59.60% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 78.19% |
| Amgen, Inc. | 56.26% |
| Anika Therapeutics, Inc. | 132.4% |
| BioCryst Pharmaceuticals, Inc. | 14.57% |
| Imunon, Inc. | -73.88% |